Stockscreener 앱 받기
1.16
2.63%
0.02
Vivos Therapeutics Inc 주식(VVOS)의 최신 뉴스
Vivos Therapeutics gains Nevada insurance network access - Investing.com
Vivos Therapeutics Reports that Supported Professional Practices Have Achieved 'In-Network' Status Across Multiple Commercial Health Insurers and Medicare in Key Nevada Market - The Manila Times
More Las Vegas sleep apnea patients gain coverage as Vivos cuts costs - Stock Titan
Aug Swings: Will Vivos Therapeutics Inc benefit from government policy2026 Top Gainers & Community Shared Stock Ideas - baoquankhu1.vn
Decliners Report: Is Vivos Therapeutics Inc in a long term uptrend2026 Fundamental Recap & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
If You Invested $1,000 in Vivos Therapeutics Inc (VVOS) - Stock Titan
SoundHealth Partners With Vivos Therapeutics to Expand Sleep Tech Access - Medical Product Outsourcing
Vivos Therapeutics (VVOS) to Release Quarterly Earnings on Monday - Defense World
Is Vivos Therapeutics Inc part of any ETFQuarterly Portfolio Report & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
Vivos Therapeutics, Inc. Study Affirms Link Between Dental Morphology and Obstructive Sleep Apnea Severity - Quiver Quantitative
Aug Breakouts: Is Vivos Therapeutics Inc part of any ETFFed Meeting & Weekly Top Performers Watchlists - baoquankhu1.vn
Winners Losers: Will Vivos Therapeutics Inc benefit from government policyWeekly Stock Summary & Weekly Return Optimization Plans - baoquankhu1.vn
Bearish Setup: Is Vivos Therapeutics Inc part of any ETF2025 Technical Patterns & AI Forecasted Entry and Exit Points - baoquankhu1.vn
New to The Street to Broadcast Executive Leadership Interviews Featuring Medicus Pharma Ltd. (NASDAQ:MDCX), CitroTech (NYSE:CITR), Vivos Therapeutics, Inc. (NASDAQ:VVOS), and Virtuix Holdings ($VTIX) on Bloomberg Television Tonight at 6:30 PM - ACCESS Newswire
VVOS Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Aug Sentiment: Can Vivos Therapeutics Inc maintain its current growth rateChart Signals & Low Drawdown Momentum Ideas - baoquankhu1.vn
Vivos Therapeutics (NASDAQ:VVOS) Stock Price Down 6.7% – Here’s What Happened - Defense World
CEO Moves: What are Complete Solaria Inc Equity Warrants recent SEC filings showingJuly 2025 Technicals & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
What dividend growth rate does Vivos Therapeutics Inc. offerProduct Launch & Low Drawdown Trading Strategies - mfd.ru
New to The Street to Broadcast Show #726 on Bloomberg at 6:30 PM EST Featuring Vivos Therapeutics (NASDAQ:VVOS), Aeries Technology (NASDAQ:AERT), Virtuix Holdings (NASDAQ:VTIX), and Stardust Power (NASDAQ:SDST) - facilitiesmanagement-now.com
What are Vivos Therapeutics Inc.’s earnings expectationsIPO Watch & Free High Return Stock Watch Alerts - mfd.ru
VVOS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Retail Surge: Can Vivos Therapeutics Inc maintain its current growth rate2025 Valuation Update & Real-Time Buy Signal Notifications - baoquankhu1.vn
Is Vivos Therapeutics Inc. showing insider buying2025 Price Targets & Verified Swing Trading Watchlists - mfd.ru
VIX Spike: How does Vivos Therapeutics Inc score in quality rankingsEarnings Growth Report & Expert Curated Trade Setups - baoquankhu1.vn
Will Vivos Therapeutics Inc. benefit from government policyDollar Strength & Weekly Top Stock Performers List - mfd.ru
Gap Down: Is Vivos Therapeutics Inc part of any ETF2025 Technical Overview & Consistent Profit Focused Trading Strategies - baoquankhu1.vn
Can Vivos Therapeutics Inc. stock hit record highs againJuly 2025 Analyst Calls & High Conviction Buy Zone Alerts - mfd.ru
Earnings Update: How correlated is Vivos Therapeutics Inc to the S P5002025 Macro Impact & Fast Moving Trade Plans - baoquankhu1.vn
Vivos Therapeutics Appoints Gregg Johnson to Board - The Globe and Mail
Vivos Therapeutics Appoints Gregg C. E. Johnson to Board of Directors - TradingView
Vivos Therapeutics, Inc. Appoints Gregg C. E. Johnson as Independent Director of the Board and Compensation Committee of the Board, Effective February 4, 2026 - marketscreener.com
Vivos Therapeutics to Distribute SoundHealth’s FDA-Cleared Sonu and Spatial Sleep Bands - HIT Consultant
Buyout Rumor: Will Vivos Therapeutics Inc benefit from government policyJuly 2025 Final Week & Stock Market Timing Techniques - baoquankhu1.vn
Vivos Therapeutics and SoundHealth collaborate to expand access to groundbreaking FDA-cleared allergy and sleep technologies - marketscreener.com
Vivos Therapeutics and SoundHealth Announce Collaboration to Expand Access to SoundHealth’s Groundbreaking FDA-Cleared Allergy and Sleep Technologies - The Manila Times
Vivos Therapeutics Collaborates with SoundHealth to Enhance Airway and Sleep Health Solutions - Quiver Quantitative
Sound-based allergy and sleep bands join Vivos dentist network - Stock Titan
VIVOS Therapeutics, Inc. ($VVOS) Signs 12-Part Media Series with New to The Street - Eagle-Tribune
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains This Quarter - Benzinga
Vivos Therapeutics, Inc. (NASDAQ:VVOS) Receives $4.92 Consensus PT from Brokerages - Defense World
Aug Catalysts: Is Vivos Therapeutics Inc showing insider buyingNew Guidance & Safe Entry Momentum Stock Tips - baoquankhu1.vn
Income Plays: What is the PEG ratio of CHSCNMarket Risk Analysis & Reliable Price Breakout Alerts - baoquankhu1.vn
Global Sleep Apnea Devices Market is Expected to Cross the USD 15 Billion Mark by 2032 | DelveInsight - GlobeNewswire Inc.
Vivos Therapeutics Announces Closing of Exercise of Warrants for $4.64 Million Gross Proceeds - The Manila Times
Vivos Therapeutics Closes Exercise of 1.98M Warrants, Raising $4.64M - intellectia.ai
Vivos Therapeutics, Inc. Closes Exercise of Warrants Raising Approximately $4.64 Million for Working Capital - Quiver Quantitative
Sleep apnea device maker Vivos raises $4.64M in repriced warrant deal - Stock Titan
Vivos Therapeutics Completes Warrant Inducement Financing Transaction - TipRanks
Vivos Therapeutics Signs Warrant Inducement Agreement With Institutional Investor - TradingView
Chipmakers Recap: What is the dividend yield of Vivos Therapeutics IncAnalyst Upgrade & Low Risk High Reward Ideas - baoquankhu1.vn
Vivos Therapeutics (NASDAQ:VVOS) and Akebia Therapeutics (NASDAQ:AKBA) Head to Head Contrast - Defense World
Vivos Announces Warrant Exercise Agreement - Dentistry Today
0.00%
0.00%
자본화:
|
볼륨(24시간):